ADX48621
ADX48621-201
Phase 2 small_molecule completed
Quick answer
ADX48621 for Parkinson's Disease is a Phase 2 program (small_molecule) at Addex Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Addex Therapeutics
- Indication
- Parkinson's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed